Evidence map›Paper›PMID 38371733›Full record

ArticleACS polymers Au2024

Antimicrobial Peptide-Poly(ethylene glycol) Conjugates: Connecting Molecular Architecture, Solution Properties, and Functional Performance.

Zixian Cui, Matthew A Crawford, Blake A Rumble, Megan M Krogh, Molly A Hughes, Rachel A Letteri

Open access · goldAbstract read
In one paragraph

Article in ACS polymers Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zixian CuiDepartment of Chemical Engineering, University of Virginia, Charlottesville, Virginia 22903, United States.
Matthew A CrawfordDivision of Infectious Diseases & International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, United States.ORCID https://orcid.org/0000-0003-0404-0061
Blake A RumbleDivision of Infectious Diseases & International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, United States.
Megan M KroghDivision of Infectious Diseases & International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, United States.
Molly A HughesDivision of Infectious Diseases & International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, United States.
Rachel A LetteriDepartment of Chemical Engineering, University of Virginia, Charlottesville, Virginia 22903, United States.ORCID https://orcid.org/0000-0002-2919-203X
University of Virginia · US

Funding

A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteriaR01AI150941 · NIAID · UNIVERSITY OF VIRGINIA · PI HUGHES, MOLLY A · 2020 to 2024
$3.1M
Optimizing therapeutic peptide presentation within polymersR35GM147424 · NIGMS · UNIVERSITY OF VIRGINIA · PI Rachel Letteri · 2022 to 2026
$1.8M
NIAID NIH HHS R01 AI150941NIGMS NIH HHS R35 GM147424
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics for treating infections caused by drug-resistant bacteria; yet, many peptides are limited by toxicity to eukaryotic cells and instability in biological environments. Conjugation to linear polymers that reduce cytotoxicity and improve stability, however, often decreases antimicrobial activity. In this work, we combine the biocompatibility advantages of poly(ethylene glycol) (PEG) with the efficacy merits of nonlinear polymer architectures that accommodate multiple AMPs per molecule. By conjugating a chemokine-derived AMP, stapled Ac-P9, to linear and star-shaped PEG with various arm numbers and lengths, we investigated the role of molecular architecture in solution properties (i.e., ζ-potential, size, and morphology) and performance (i.e., antimicrobial activity, hemolysis, and protease resistance). Linear, 4-arm, and 8-arm conjugates with 2-2.5 kDa PEG arms were found to form nanoscale structures in solution with lower ζ-potentials relative to the unconjugated AMP, suggesting that the polymer partially shields the cationic AMP. Reducing the length of the PEG arms of the 8-arm conjugate to 1.25 kDa appeared to better reveal the peptide, seen by the increased ζ-potential, and promote assembly into particles with a larger size and defined spherical morphology. The antimicrobial effects exerted by the short 8-arm conjugate rivaled that of the unconjugated peptide, and the AMP constituents of the short 8-arm conjugate were protected from proteolytic degradation. All other conjugates examined also imparted a degree of protease resistance, but exhibited some reduced level of antimicrobial activity as compared to the AMP alone. None of the conjugates caused significant cytotoxic effects, which bodes well for their future potential to treat infections. While enhancing proteolytic stability often comes with the cost of lower antimicrobial activity, we have found that presenting AMPs at high density on a neutral nonlinear polymer strikes a favorable balance, exhibiting both enhanced stability and high antimicrobial activity.

Identifiers

PMID38371733
PMCPMC10870750
OpenAlexW4389686636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.